Waters, Quest Diagnostics Collaborate to Expand Access to At-Home HPV Screening for Cervical Cancer

MT newswire2026/10/20 13:14

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

09:14 AM EDT, 10/20/2026 (MT Newswires) -- Waters (WAT) and Quest Diagnostics (DGX) have entered into a collaboration aiming to widen US access to at-home HPV screening for cervical cancer, the two companies said Tuesday. Starting in 2027, the collaboration will provide access to the Onclarity Self-Collection Kit through clinical, health plan, and consumer health channels, as well as Quest's patient service centers, according to a statement. Financial terms were not disclosed.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Morgan Stanley strategist Michael Wilson pointed out that the quality factor has risen by about 6% since mid-August, reaching a new 52-week high, while the equal-weighted S&P 500 index has fallen by nearly 4% over the same period. Currently, financial conditions have tightened to their highest levels since 2022, and the outperformance of large-cap stocks is masking a significant pullback in other individual stocks. He stated that medium-term corrections in the stock market often end with a catch-down in high-quality stocks.

华尔街见闻•2026/10/20 14:53